$3.70
0.54%
Nasdaq, Oct 05, 10:19 am EDT. Market open.
ISIN
US04301G2012
Symbol
ARTL

Artelo Biosciences Inc Target price 2026 - Analyst rating & recommendation

Artelo Biosciences Inc Classifications & Recommendation

Hold
50%
Sell
50%

Artelo Biosciences Inc Price Target

Target Price $30.60
Price $3.68
Potential
Number of Estimates 3
3 Analysts have issued a price target Artelo Biosciences Inc 2027 . The average Artelo Biosciences Inc target price is $30.60. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 6 analysts: 0 Analysts recommend Artelo Biosciences Inc to buy, 3 to hold and 3 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Artelo Biosciences Inc stock has an average upside potential 2027 of . Most analysts recommend the Artelo Biosciences Inc stock at Sell or hold.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share $ -37.55 -10.04
31.58% 73.26%
P/E negative

3 Analysts have issued a Artelo Biosciences Inc forecast for earnings per share. The average Artelo Biosciences Inc EPS is

$-10.04
unlock
. This is
114.99% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-10.33 121.20%
unlock
, the lowest is
$-9.64 106.42%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-37.55 31.58%
2026
$-10.04 73.26%
unlock
2027
$-5.39 46.31%
unlock
2028
$12.85 338.40%
unlock

P/E ratio

Current -0.79 161.53%
2026
-0.37 53.05%
unlock
2027
-0.68 83.78%
unlock
2028
0.29 142.65%
unlock

Current Artelo Biosciences Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Maxim Group
Locked
➜
Locked
Locked Nov 19 2025
D. Boral Capital
Locked
➜
Locked
Locked Sep 08 2025
D. Boral Capital
Locked
➜
Locked
Locked Aug 26 2025
D. Boral Capital
Locked
➜
Locked
Locked Aug 18 2025
D. Boral Capital
Locked
➜
Locked
Locked Aug 06 2025
D. Boral Capital
Locked
➜
Locked
Locked Aug 04 2025
D. Boral Capital
Locked
➜
Locked
Locked Jul 08 2025
Analyst Rating Date
Locked
Maxim Group:
Locked
➜
Locked
Nov 19 2025
Locked
D. Boral Capital:
Locked
➜
Locked
Sep 08 2025
Locked
D. Boral Capital:
Locked
➜
Locked
Aug 26 2025
Locked
D. Boral Capital:
Locked
➜
Locked
Aug 18 2025
Locked
D. Boral Capital:
Locked
➜
Locked
Aug 06 2025
Locked
D. Boral Capital:
Locked
➜
Locked
Aug 04 2025
Locked
D. Boral Capital:
Locked
➜
Locked
Jul 08 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today